WallStreetZenWallStreetZen

NASDAQ: CRDF
Cardiff Oncology Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Cardiff Oncology earnings were -$45.5M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest CRDF earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$11.8M, down 0.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CRDF reported annual earnings of -$45.5M, with 9.6% growth.

CRDF earnings history

Current Revenue
$683.0k
Current Earnings
-$45.5M
Current Profit Margin
-6,655.2%

CRDF Return on Equity

Current Company
-74%
Current Industry
-2%
Current Market
34.1%
CRDF's Return on Equity (-74%)... subscribe to Premium to read more.
High Return on Equity Performance

CRDF undefined

Current Company
-60.6%
Current Industry
-0.4%
CRDF is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CRDF announces earnings.

CRDF undefined

Current Company
-54.24%
Current Industry
5.9%
CRDF's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CRDF vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CRDF-$45.03M-$45.46MN/A-$0.95
IPHA-$47.28M-$53.77MN/A-$0.66
INMB-$42.08M-$42.08MN/A-$2.11
DRTS-$26.34M-$31.75MN/A-$0.45
ACTU-$27.27M-$27.29MN/A-$3.26
View Top Biotech Stocks

Cardiff Oncology Earnings Reports & History FAQ

What were Cardiff Oncology's earnings last quarter?

On CRDF's earnings call on Invalid Date, Cardiff Oncology (NASDAQ: CRDF) reported Q4 2024 earnings per share (EPS) of -$0.21, up 0% year over year. Total CRDF earnings for the quarter were -$11.79 million. In the same quarter last year, Cardiff Oncology's earnings per share (EPS) was -$0.21.

If you're new to stock investing, here's how to buy Cardiff Oncology stock.

Is Cardiff Oncology profitable or losing money?

As of the last Cardiff Oncology earnings report, Cardiff Oncology is currently losing money. Cardiff Oncology's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$45.43 million, a 9.63% increase year over year.

What was CRDF's earnings growth in the past year?

As of Cardiff Oncology's earnings date in Invalid Date, Cardiff Oncology's earnings has grown year over year. CRDF earnings in the past year totalled -$45.46 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.